ClinicalTrials.gov
public full text
Public Domain
The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC
Triple-negative breast cancer (TNBC) is biologically aggressive and has limited systemic treatment options, often compounded by treatment resistance. Cell state transitions, e.g. epithelial-to-mesenchymal transition (EMT) govern cancer cell behaviour. The investigators hypothesize that by inducing change in cell state change, TNBC cells that have manifested taxane-resistance will be more sensitized to subsequent chemotherapy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Bexarotene in Treating Patients With Metastatic Breast Cancer#874121
- Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer#1096636
- Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer#1351075
- The effect of cannabidiol on cancer-pathway genes in doxorubicin-sensitive and resistant breast cancer cells#211782
- Combination Therapy for BRAF-V600E Metastatic CRCm#1059781
Record · ID 1309010
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive